Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.40 and traded as low as $2.18. Creative Medical Technology shares last traded at $2.27, with a volume of 8,355 shares changing hands.
Creative Medical Technology Price Performance
The company has a 50-day simple moving average of $2.40 and a 200 day simple moving average of $3.11.
Creative Medical Technology Company Profile
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Recommended Stories
- Five stocks we like better than Creative Medical Technology
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Oilfield Leader SLB: An AI Name You Need to Know
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
